Serie de Casos Retrospectiva de las Características Clínicas, del Manejo y Resultados de los Pacientes con COVID-19 en hospitales privados de la región metropolitana en la República de Panamá

[Clinical Characteristics, Management and Outcomes of patients with COVID-19 in private hospitals in the Republic of Panama, 2020]

Fatima Beatriz Arango Carles1, Natalia Alejandra Ortega Castillo1, Juan Carlos Casaboza Xesspe2, Migdonio Alberto González Gómez2, Francisco Roberto Arango Carles3, Antonio Cachafeiro Vilar4, Idalina del Carmen Cubilla Batista5, José Walter Valverde6, Nicole Gabriela Tinker Jaén7

1. Dirección de Investigación, Universidad Latina de Panamá. Dirección de Investigación Científica y Desarrollo, SENACYT; 2. Grupo de Investigación, Universidad Tecnológica de Panamá, Panamá.; 3. Sociedad Inteligencia Informática, Dirección de Investigación Científica y Desarrollo, SENACYT, Panamá; 4. Dirección Médica, Hospital Punta Pacífica, Pacífica Salud Panamá, Panamá. ; 5. Hospital Punta Pacífica, Pacífica Salud, Panamá, Panamá; 6. Unidad de Cuidados Intensivos, Hospital Paitilla, Panamá, Panamá; 7. Hospital Nacional, Panamá, Panamá..

Publicado: 2022-01-05

Descargas

Resumen

Introducción: El 9 de marzo de 2020 se confirma el primer caso de COVID-19 en la República de Panamá. Según el reporte #46 de Panamá emitido por la OPS el 26 de enero de 2021, Panamá es el segundo país de las Américas con más alta incidencia después de Estados Unidos.

Métodos: El diseño del estudio es observacional retrospectivo. En este estudio participaron 140 pacientes de 3 instituciones privadas localizadas en el área metropolitana de la República de Panamá.

Resultados: De la muestra, 65.71% eran hombres y 34.29% eran mujeres, 72 (51.43%) pacientes fueron hospitalizados. La edad media fue de 48.39 años. El 49% de los pacientes presentaron antecedentes personales patológicos, el más común fue hipertensión arterial (63.27%). Los síntomas más frecuentes encontramos fiebre (71.43%), tos (61.43%), fatiga (50.71%) y disnea (32.86%). Del total de pacientes, 55.71% recibió tratamiento intrahospitalario, 11.51% fue admitido a UCI, 9.29% sufrió complicaciones y las más frecuente fue falla respiratoria (61.54%). De los medicamentos utilizados en ese periodo de tiempo lo más comúnmente usado fue la hidroxicloroquina (91.03%) y la azitromicina (84.62%).

Conclusiones: Se encontraron resultados similares a estudios descriptivos realizados en distintos países con modelos similares al nuestro.

 


Abstract

Introduction: The first case of COVID-19 in the Republic of Panama was confirmed on March 9 2020. In the Panama #46 report issued by PAHO on January 26, 2021, Panama was the second country in the Americas with the highest incidence of COVID-19 after the United States.

Methods: The design of the study is a retrospective observational study of 140 patients from 3 private hospitals located in the metropolitan area of the Republic of Panama.

Results: Of the sample, 65.71% were men and 34.29% were women, 72 (51.43%) patients were hospitalized. The median age was 48.39 years. 49% of the patients presented a pathological personal history, the most common was arterial hypertension (63.27%).  Of the sample, 65.71% were men and 34.29% were women, 72 (51.43%) patients were hospitalized. The average age was 48.39 years. 49% of patients had a pathological personal history where high blood pressure was the most frequent (63.27%). The most common symptoms were fever (71.43%), cough (61.43%), fatigue (50.71%) and dyspnea (32.86%). Of the total number of patients, 55.71% received in-hospital treatment, 11.51% were admitted to the ICU, 9.29% suffered complications, the most frequent was respiratory failure (61.54%). Of the drugs used in that time period, the most commonly used were hydroxychloroquine (91.03%) and azithromycin (84.62%).

Conclusions: Similar results were found to descriptive studies carried out in different countries with models similar to ours.

Citas

[1] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020 Mar 28 [cited 2021 Mar 11];395(10229):1054-62. Available from: https://doi.org/10.1016/ DOI: https://doi.org/10.1016/S0140-6736(20)30566-3DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

[2] World Health Organization. WHO Timeline - COVID-19. Who. 2020;

[3] Ministerio de Salud de Panamá. Panamá confirma primer caso de COVID-19 | Ministerio de Salud de la República de Panamá [Internet]. Ministerio de Salud de Panamá (MINSA) 2020. Available from: http://minsa.gob.pa/noticia/panama-confirma-primer-caso-de-covid-19

[4] Ministerio de Salud de Panamá. Decreto ejecutivo 504 [Internet]. Panama; 2020. p. 1-25. Available from: https://www.gacetaoficial.gob.pa/pdfTemp/28986_A/GacetaNo_28986a_20200323.pdf

[5] OPS. Reporte No. 46 - COVID-19 [Internet]. 2021. Available from: https://www.paho.org/es/documentos/covid-19-informe-situacion-panama-ndeg46-enero-26-2021

[6] Covid Performance - Lowy Institute [Internet]. [cited 2021 Mar 10]. Available from: https://interactives.lowyinstitute.org/features/covid-performance/#rankings

[7] Casaboza JC, Cárdenas DE. Analysis and Modeling of Dynamic Behavior of the COVID-19 Outbreak : Study Case of Panama. IEEE Lat Am Trans [Internet]. 2020 [cited 2021 Mar 11];19(6):893-900. Available from: https://latamt.ieeer9.org/index.php/transactions/article/view/4227 DOI: https://doi.org/10.1109/TLA.2021.9451233DOI: https://doi.org/10.1109/TLA.2021.9451233

[8] Franco D, Gonzalez C, Abrego LE, Carrera JP, Diaz Y, Caicedo Y, et al. Early transmission dynamics, spread, and genomic characterization of SARS-CoV-2 in Panama. Emerg Infect Dis [Internet]. 2021 Feb 1 [cited 2021 Mar 11];27(2):612-5. Available from: https://doi.org/10.3201/eid2702.203767 DOI: https://doi.org/10.3201/eid2702.203767DOI: https://doi.org/10.3201/eid2702.203767

[9] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 Mar;323(11):1061-9. Available from: https://doi.org/10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585DOI: https://doi.org/10.1001/jama.2020.1585

[10] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. Lancet [Internet]. 2020;395(10223):497-506. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext DOI: https://doi.org/10.1016/S0140-6736(20)30183-5DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

[11] Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinical and Epidemiological Characteristics of Patients Diagnosed With Covid-19 in a Tertiary Care Center in Mexico City: a Prospective Cohort Study. Rev Invest Clin. 2020;72(3):165-77. DOI: https://doi.org/10.24875/RIC.20000211DOI: https://doi.org/10.24875/RIC.20000211

[12] Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020. DOI: https://doi.org/10.1016/j.tmaid.2020.101623DOI: https://doi.org/10.1016/j.tmaid.2020.101623

[13] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA - J Am Med Assoc. 2020;

×